Caring for Your Vision

Caring for
your vision

When living with wet age-related macular degeneration (wet AMD), it's important to stay on track with your treatment plan and monitor your vision for changes between appointments. Take the following steps to create your own vision care routine.

1. Stay on track with your treatment plan

Wet AMD is a chronic condition, but it may be managed with regular treatment.

Use these tips to start a vision care routine and be best prepared for your appointments.

Support network icon

Build a support network. This includes loved ones, your eye care team, low-vision specialists, and anyone else who helps and encourages you.

Discussion guide icon

Prepare for your doctor's appointments. Appointments are a great time to get answers. Not sure what to ask? Use the BEOVU Discussion Guide to get started.

Vision journal icon

Create a vision journal. Keep your appointments, notes, vision changes, and questions for your doctor all in one place. Bring this to every appointment.

Keep up with your scheduled appointments and follow your doctor's advice.

2. Monitor your vision for changes

Use an Amsler Grid to check your vision at least once a week. By making this part of your routine, you can alert your doctor if you notice any vision changes.

Click on the tabs below to see how vision may be affected with wet AMD.

Normal

Wavy

Spots

Combination

In a healthy eye, the lines of an Amsler grid will appear straight.

In a healthy eye, the lines of the Amsler Grid will appear straight.

With wet AMD, the straight lines of the Amsler Grid may appear wavy.

With wet AMD, the straight lines of the Amsler Grid may appear wavy.

With wet AMD, the straight lines of the Amsler Grid may have a gray, white, or red blind spot in or near the center.

With wet AMD, the straight lines of the Amsler Grid may have a gray, white, black, or red blind spot in or near the center.

With wet AMD, the straight lines of the Amsler Grid may appear to be wavy or blocked with spots.

With wet AMD, the straight lines of the Amsler Grid may appear to be wavy or blocked with spots.

Check your vision at least once a week.
Download your own Amsler Grid here

Text
size

Contrast

Back to Top Back to Top

INDICATIONS

IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

COLLAPSE

EXPAND

BEOVU® (brolucizumab-dbll) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).

You should not use BEOVU if you have an infection in or around the eye, eye inflammation, or if you are allergic to brolucizumab or any of the ingredients in BEOVU.

BEOVU is a prescription medicine given by injection into the eye. Injections in the eye, including BEOVU, may cause an infection of the eye or retinal detachment (separation of retina from the back of the eye). It is important to contact your doctor right away if your eye becomes red, sensitive to light, painful, or you develop any change in your vision.

Increased eye pressure has been seen within 30 minutes of an eye injection, including BEOVU. Sustained increases in eye pressure also have been reported. Your doctor should monitor for this when you receive a BEOVU injection.

There is a potential risk of stroke, heart attack, or blood clots in patients receiving eye injections of vascular endothelial growth factor (VEGF) inhibitor drugs, including BEOVU. Sudden vision loss due to blockage of the blood vessels in the back of the eye and inflammation of blood vessels in the back of the eye have been reported.

The most common side effects reported in patients receiving BEOVU in the wet AMD studies were reduced clarity in vision, cataract, broken blood vessels in the eye, eye pain, and vitreous floaters (moving spots in the field of vision). The most common side effect reported in patients receiving BEOVU in the DME studies was broken blood vessels in the eye.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

Please see full Prescribing Information.

INDICATIONS

BEOVU® (brolucizumab-dbll) injection is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) and Diabetic Macular Edema (DME).